Protas launches early market engagement for unified clinical trials management platform
Protas publishes a prior information notice for provision of cloud-based clinical trials management platform.
The latest in smarter trials
As a not-for-profit, our mission is to enable whole-system change in clinical trials. This means sharing our approach and knowledge with our community. From news about Protas, our partnerships and trials, to advice and guidance, discover more about our world.
Protas welcomes four new starters
To drive forward its mission of reducing barriers in the development of treatments for common diseases, Protas welcomes new team.
Protas launches with Sanofi as its first partner
The new not-for-profit designing and delivering smarter clinical trials has launched with the biopharma Sanofi as first partner.
Protas welcomes the Good Clinical Trials Collaborative
Protas becomes the new host organisation for the Good Clinical Trials Collaborative.
Protas interviewed by The Lancet for new Research Focus
The medical journal has published an in-depth article exploring Protas’ work and mission.
Protas receives support from Schmidt Futures
Protas has been awarded a grant by the philanthropic initiative founded by Eric and Wendy Schmidt.
Protas receives grant from venture capital firm GV
The £5m grant recognises the unique ability of Protas to deliver better clinical trials.
Protas appoints Beth Thompson to its board
Protas is pleased to announce the appointment of Dr Beth Thompson MBE to its Board of Directors.
Protas announces grant funding from Flu Lab
Protas has announced a £5 million grant from Flu Lab, a charitable organisation fuelling bold approaches to defeat influenza.
Protas signs strategic collaboration with Regeneron
Protas and Regeneron, the leading biotechnology company, announce a strategic, long-term collaboration.
Protas IT contract awarded to Slalom
Protas awards the contract to develop and operate a unified clinical trials management platform to Slalom.
Protas signs strategic partnership with Moderna
Moderna is a leading biotechnology company pioneering mRNA. Its mission is to deliver the greatest possible impact to people.